| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Marshall Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Marshall Medical Center is based in Placerville, CA. You can find more information on Marshall Medical Center at www.marshallmedical.org
PeriGen, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Braswell'S Chateau Villa is a Redlands, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vasomedical, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Westbury, NY. To find more information about Vasomedical, Inc., please visit www.vasomedical.com